At LAMPF an 800-MeV proton accelerator is used to produce intense beams of secondary protons, pi mesons, and muons which are being employed in several areas of biomedical research. The primary proton beam is used to produce short-lived radioisotopes of clinical interest. Carefully tailored secondary proton beams are used to obtain density reconstructions of samples with a dose much less than that required by x-ray CT scanners. The elemental composition of tissue samples is being determined non-destructively with muonic x-ray analysis. Finally, an extensive program, with physical, biological, and clinical components, is underway to evaluate negative pi mesons for use in cancer radiotherapy. The techniques used in these experiments and recent results are described.
Introduction
At the Clinton P. Anderson Meson Physics Facility (LAMPF) a linear accelerator is used to generate intense beams of 800-MeV protons. These protons, interacting with appropriate targets, produce copious fluxes of secondary protons, neutrons, pi mesons (pions), and muons which can be delivered to a number of different experimental areas shown in Fig. 1 . LAMPF is a national facility, open to all qualified researchers, and is presently providing a proton current of 500 pA with the design goal of 1 mA expected in 1980.
The basic research program at LAMPF involves experiments in nuclear physics, medium energy particle physics, nuclear chemistry, and solid-state physics. Largely as a result of the high beam intensities, an extensive applied research program is also underway which includes materials analysis investigations with protons, muons, and neutrons; radiation damage studies with protons and neutrons; radioisotope production with protons; and cancer radiotherapy with negative pions. Accelerator technology is also being transferred to biomedicine through the use of localized rf current fields to produce hyperthermia for the treatment of tumors. In this paper the subset of applied research at LAMPF aimed at biomedical applications is discussed.
Radioisotope Production
The primary proton beam passes through three pion production targets and about 50% of the original current is available for radioisotope production at the beam stop area. 1 Up to nine stringers can be remotely . , W n . .w .as t 0 Fig. 1 Experimental areas at LAMPF. Area A is used primarily and nuclear chemistry, and Area C for nuclear physics.
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0018-9499/79/0200-0139$00.75&. 1979 IEEE inserted into and retracted from the bpam line; each stringer can contain a 2.5-cm-thick, water-cooled target in which radioisotopes are produced through sity distribution within the sample may be reconstructed, using computer algorithms, in a manner analogous to that employed in commercial x-ray CT scanners which are being widely used to detect and localize internal abnormalities like tumors. It is expected on theoretical grounds that scans with charged particles like protons should require substantially less dose than x-ray scans to achieve a given density resolution.
At LAMPF a channel was tuned to provide a spatially collimated secondary beam of protons with an energy of 200 MeV and an energy spread of 0.4%. A proton computed tomography experiment was carried out using the arrangement shown in Fig. 2 .2 A phantom, with inhomogeneities designed to provide quantitative determination of spatial and density resolution, was immersed in a water bath to limit the required dynamic range and placed in the proton beam. The residual energy of the protons was measured with a hyperpure Ge detector, and a multiwire proportional counter was used to measure the proton exit position so that a correction for multiple scattering could be applied. Tests indicated that a density difference of less than .01% could be detected. The phantom was translated and rotated to provide a large number of views, and the density distribution was reconstructed using the energy and position measurements on some 6 x 10' protons. The reconstruction is shown in Fig. 3 . Subsequently, the phantom was scanned with a commercial x-ray scanner; the proton dose was a factor of about five less than the x-ray dose for a similar reconstructed density resolution (0.4% for 1 cm object).
Future experiments using fixed and fresh human tissue specimens and high data acquisition rates will be aimed,at determining whether, in addition to the dose advantages protons also provide a contrast advantage 140 IPGe Fig. 2 The experiment arrangement for evaluating proton computed tomography including test phantom, proportional chamber to determine proton exit position, scintillators to trigger data acquisition system, and proton energy detector. Muonic X-Ray Analysis LAW1PF has a channel which is designed to provide intense beams of energetic muons, the decay products of pions. When negative muons are implanted in a sample, they slow to an energy of a few eV and are captured by a nucleus to form a muonic atom. The muon cascades down to more tightly bound orbits in the atom emitting x rays whose energies are characteristic of the capturing element as is the case with electron transitions. The entire process occurs in a time short compared to the muon lifetime of 2 x 10 6s. Since the mass of the muon is about 200 times that of the electron, the x rays are much more energetic than electronic characteristic x rays; muonic x rays easily escape bulk samples with low absorption and may be detected with good efficiency by Ge(Li) detectors. In a mixture of elements the probability of muon capture as a function of atomic number I can be empirically determined (and approximately predicted theoretically) so analysis of the intensities and energies of the x rays provides a quantitative determination of the elemental composition of the sample.
Muonic x-ray analysis is non-destructive and, although not suitable for trace element analysis, the technique can be used to detect element concentrations down to about the 0.1% level. Also the interior of large samples can be interrogated, and some spatial selectivity can be achieved by varying the muon beam energy and thus the stopping region. Finally, in contrast to most conventional analytical techniques, muonic x-ray analysis can be used to detect all elements with atomic numbers greater than two; in particular, it can be applied to analyses of bulk samples of organic materials whose primary constituents are low-Z elements.
A number of samples of biological and environmental interest have been analyzed with muons at LAMPF, including human tissues and organs,3coal samples, and reactor fuel rod materials. In Fig. 4 the muonic xray spectrum from a normal human liver sample is shown with lines from C, N and 0. A similar spectrum obtained from a cirrhotic liver has been analyzed to reveal about a 6% difference in the oxygen to carbon ratio, reflecting a larger fat concentration. This suggests the possibility of using muonic x-ray analyses for the in vivo diagnosis of diseases which give rise to abnormal concentrations of elements such as hemochromatosis, cirrhosis, osteoporosis, and perhaps some types of cancer. An experiment will be performed soon to ascertain the utility of spread (which produces a narrow dose peak) in order to produce sharp edges in the dose distribution. To fill a large tumor volume, this narrow peak is spread in depth by a programable, hydraulically actuated rangeshifter.5 The channel contains slits for beam definition and safety purposes, an ionization chamber for monitoring dose, and instrumentation for mapping the phase space of the particles. A computer is used to control and monitor all of the hardware in the pion delivery system, motion of the patient treatment couch, and the patient treatment itself.
Beam Development and Characterization
The magnets in the channel are tuned with multiwire proportional chambers to shape pion beams of various sizes for therapy with the objective of maximizing dose rate and uniformity of dose in the field.6 Timeof-flight techniques are used to measure the low LET electron and muon contamination flux which is typically about 20% of the pion flux. A catalog of beam tunes has been developed which, in conjunction with appropriate range shifter functions,provides channel parameters for producing stopping pion distributions in volumes ranging from 3 x 3 x 3 cm3 to 17 x 17 x 17 cm3 at three different energies corresponding to maximum penetration depths of 12, 18, and 26 cm.
The three-dimensional dose distributions for the various beams are measured in water and effects of collimators and inhomogeneities assessed.7 Also, the relatively small dose outside the stopping region due to beam contaminants and neutrons from the capture process is measured for different beams. Finally, microdosimetric measurements are made, using very thin Si(Li) detectors and thimble ionization chambers to determine quantitatively the LET distribution in the volume. 8, 9 The high-LET component of the dose varies throughout the spread peak, depending upon the ratio of passing to stopping pions which produce the dose; the goal is to correlate LET measurements with radiobiology or clinical results to establish how to shape dose distributions to produce uniform biological effect. Several dose distributions are shown in Fig. 6 ; that labeled flat biological dose is tailored so that the increased high-LET dose in the downstream portion is compensated by a decreased physical dose. The Radi obi ol ogy
The major aims of the radiobiology effort are 1) to study effects of pions on normal tissues using mouse lung, heart, kidney, etc. irradiations, to help guide the clinical trials, 2) to evaluate variation in biological effectiveness for different dose distributions using cell systems, mouse tumors, and multicellular tumor spheroids and 3) to investigate fundamentals of radiobiological action with mixed-field radiation. In a spread peak pions produce a biological effect ranging from about 20% to 60% greater than the x-ray control radiation and are about 10% to 25% more effective than x rays in overcoming intrinsic radioresistance due to hypoxia. Recent experiments by Yuhas11 in which x rays and pions are applied in a variable time sequence to cell systems seem to indicate that the mechanism of action for pions may involve the high-LET component of the dose inhibiting repair of sublethal injury caused by the low-LET component.
Treatment Planning and Visualization
Computerized treatment planning is essential for delivering pions in an optimum manner to the unique tumor volume of a given patient. Each patient receives an x-ray computerized tomography (CT) scan which serves to determine both the location and extent of the tumor in the body and the integrated density between the patient surface and the tumor which is necessary for establishing the distribution of pion ranges required. On the basis of the CT scan a collimator is fabricated to limit the field in the transverse dimensions and a bolus is constructed to compensate for the patient inhomogeneities. The treatment planning code then transports the five-dimensional phase space characterizing the pions, muons, and electrons for an appropriate channel tune through the moving range shifter, collimator, and bolus and into the patient where the particles deposit dose in accordance with the detailed density distribution supplied by the CT scan. During the propagation of the particles the code takes into account multiple scattering, range straggling, pion and muon decay, and the high-LET dose resulting from pion capture. Isodose contours for different LET components can be calculated for evaluation by the physician. An example of a treatment plan for a pancreatic tumor utilizing parallel opposed overlapping ports is shown in Fig. 8 .
In a significant fraction of the pion captures gamma rays are produced (from charge exchange and radiative capture processes, nuclear excitation, and residual radioactive nuclei)which escape the body. The trajectory of these garmmas can be measured with collimators and detectors, thus determining the distribution of stopping pions. Experiments are underway to develop clinically useful instrumentation which will permit the stopping pion distribution to be visualized during patient treatment with a resolution of r 1 cm. When referenced to the patient anatomy this will serve as a check on the treatment planning and the performance of the channel hardware. The experimental arrangement for visualizing gammas above about 10 MeV is shown in Fig. 9 .
Patient Treatments and Results
Patients are immobilized in casts and positioned by means of a crossed-beam laser system which is duplicated in the staging area and treatment room. The patient setup configuration is shown in Fig. 10 Experimental arrangement using high-energy gammas to visualize the distribution of stopping pions. The gammas pass through a uranium collimator and, after conversion, are localized with a multiwire proportional counter. Trigger counters and absorber are used to set the gamma energy threshold.
used for treatments requiring a lateral dimension greater than 15 cm. For the treatments to date the pion beams ranged in energy from 60 to 110 MeV and the modulated pion peak was spread to dimensions up to 14 cm. 
